ADMA BIOLOGICS INC (ADMA) Stock News
NASDAQ:ADMA - Nasdaq - US0008991046 - Common Stock - Currency: USD
ADMA Latest News, Press Relases and Analysis
Would Mark Minervini consider ADMA BIOLOGICS INC (NASDAQ:ADMA) a top stock pick?
A fundamental and technical analysis of (NASDAQ:ADMA): Exploring ADMA BIOLOGICS INC (NASDAQ:ADMA)'s high growth characteristics.
Why ADMA BIOLOGICS INC (NASDAQ:ADMA) qualifies as a high growth stock.
A fundamental and technical analysis of (NASDAQ:ADMA): Is ADMA BIOLOGICS INC (NASDAQ:ADMA) suited for high growth investing?
Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates
AGIO's earnings beat estimates in the first quarter of 2025, while revenues miss the same.
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings?
Strong performance of Asceniv continues to boost ADMA. We recommend the stock to investors due to its solid long-term fundamentals.
Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
MDGL stock is rising as it reports better-than-expected first-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra sales.
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down
BHCs first-quarter 2025 adjusted earnings and revenues miss estimates. Salix performs lower than expected. Stock declines.
Has ADMA Biologics (ADMA) Outpaced Other Medical Stocks This Year?
Here is how Adma Biologics (ADMA) and Agilon Health (AGL) have performed compared to their sector so far this year.
Mentions: AGL
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know
Zacks.com users have recently been watching Adma Biologics (ADMA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y
SAGE's earnings and revenues miss estimates in the first quarter of 2025. The company focuses on the commercialization of its depression drug Zurzuvae.
Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y
RGEN reports better-than-expected first-quarter results. The company increases its total revenue (on a reported basis) guidance for 2025.
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
Conference Call Scheduled for May 7, 2025, at 4:30 p.m. ET
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
Conference Call Scheduled for May 7, 2025, at 4:30 p.m. ET...
Why GRAIL, Inc. (GRAL) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where GRAIL, Inc. (NASDAQ:GRAL) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a comeback […]
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade
Adma Biologics (ADMA) closed the most recent trading day at $24.11, moving -1.63% from the previous trading session.
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
What's Going On With ADMA Stock Monday?
ADM shares are trading higher Monday after the company announced the FDA's approval of its yield enhancement process.
IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval
The company says a new process will improve its output by 20%, benefitting revenue and earnings later this year.
Mentions: LLY
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity First U.S. Regulatory...
These Growth Stocks Are Crushing the S&P 500 in 2025. Should You Buy Them?
After a strong run for the stock market the past two years, volatility has returned in 2025. While the S&P 500 (SNPINDEX: ^GSPC) is down 8% at the time of writing, some companies that entered the year with strong momentum are holding up quite well. Shares of Palantir Technologies (NASDAQ: PLTR) and Uber Technologies (NYSE: UBER) are two of the best performing stocks in the S&P 500 this year.
BMY Beats on Q1 Earnings and Sales, Raises 2025 Outlook
BMY beats on both earnings and sales in the first quarter of 2025. The company raises its guidance for the full year.
ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying
We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock that gains or is expected to gain […]
The Hershey Company (HSY): Among Takeover Rumors Hedge Funds Are Buying
We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at where The Hershey Company (NYSE:HSY) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock that gains or is expected to gain […]
Why Super Micro Computer Inc. (SMCI) Went Up On Wednesday
We recently published a list of These 10 Firms Topped Wednesday’s Trading. In this article, we are going to take a look at where Super Micro Computer Inc. (NASDAQ:SMCI) stands against other firms that topped Wednesday’s trading. Wall Street’s major indices rebounded anew on Wednesday as worries about tariff policies and the Federal Reserve’s independence […]
Is International Business Machines Corporation (IBM) the Best Stock to Buy and Hold for 20 Years?
We recently published a list of 10 Best Stocks to Buy and Hold for 20 Years. In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against other best stocks to buy and hold for 20 years. As per Ameriprise Financials, the initial months of 2025 were tough for […]
Why Tempus AI Inc. (TEM) Went Up On Wednesday
We recently published a list of These 10 Firms Topped Wednesday’s Trading. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms that topped Wednesday’s trading. Wall Street’s major indices rebounded anew on Wednesday as worries about tariff policies and the Federal Reserve’s independence tapered […]
Is NextEra Energy, Inc. (NEE) the Best Stock to Buy and Hold for 20 Years?
We recently published a list of 10 Best Stocks to Buy and Hold for 20 Years. In this article, we are going to take a look at where NextEra Energy, Inc. (NYSE:NEE) stands against other best stocks to buy and hold for 20 years. As per Ameriprise Financials, the initial months of 2025 were tough for […]
Is Walt Disney Company (DIS) the Best Stock to Buy and Hold for 20 Years?
We recently published a list of 10 Best Stocks to Buy and Hold for 20 Years. In this article, we are going to take a look at where Walt Disney Company (NYSE:DIS) stands against other best stocks to buy and hold for 20 years. As per Ameriprise Financials, the initial months of 2025 were tough for […]
Adma Biologics (ADMA) Gains But Lags Market: What You Should Know
In the latest trading session, Adma Biologics (ADMA) closed at $21.73, marking a +1.57% move from the previous day.
GeneDx Holdings Corp. (WGS): Among the Best Multibagger Stocks to Buy According to Billionaires
We recently published a list of 10 Best Multibagger Stocks to Buy According to Billionaires. In this article, we are going to take a look at where GeneDx Holdings Corp. (NASDAQ:WGS) stands against other best multibagger stocks to buy according to billionaires. US Trade tariffs have triggered heightened volatility and amplified the downdraft in the […]
GDS Holdings Limited (GDS): Among the Best Multibagger Stocks to Buy According to Billionaires
We recently published a list of 10 Best Multibagger Stocks to Buy According to Billionaires. In this article, we are going to take a look at where GDS Holdings Limited (NASDAQ:GDS) stands against other best multibagger stocks to buy according to billionaires. US Trade tariffs have triggered heightened volatility and amplified the downdraft in the […]
Adma Biologics (ADMA) Beats Stock Market Upswing: What Investors Need to Know
Adma Biologics (ADMA) concluded the recent trading session at $21.31, signifying a +0.38% move from its prior day's close.
UnitedHealth Loses $120 Billion in Value on Stock's Worst Day Since 1998
UnitedHealth Group stock had one of its worst days ever on Thursday after the healthcare giant unexpectedly cut its profit forecast for the year.
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP
The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent meningococcal vaccination schedule.
ADMA Biologics (ADMA): Among Louis Navellier’s New Stock Picks
We recently published a list of Louis Navellier’s 10 New Stock Picks. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other Louis Navellier’s new stock picks. Navellier & Associates is an independent money management firm founded in 1987 by renowned growth analyst Louis Navellier. Based in […]
Investors seeking growth at a reasonable cost should explore ADMA BIOLOGICS INC (NASDAQ:ADMA).
Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.